European Parliament backs WHO’s Covid-19 patent pool plan
The European Parliament has voted to support a World Health Organization effort to pool patent rights and data that could help in the Covid-19 response.
Related Articles
Second-generation mosquito nets prevented 13 million malaria cases in large pilot programs
Second-generation mosquito nets prevented 13 million malaria cases and 25,000 deaths in large pilot programs.
Teladoc became a household name under Jason Gorevic. Investors wanted more
Gorevic’s departure follows a series of missed financial projections, a precipitous decline in Teladoc’s stock price, and an uninspired vision for its future.
Hospital price transparency rules are seeding a new crop of health tech startups
Hospital and health insurance pricing data surfaced by new federal transparency rules are creating an opportunity for startups to help patients fight exorbitant medical bills.
The next frontier in data privacy? Your brain
The rising use of neurotechnology devices like Emotiv’s wearable EEG and Muse headbands raises a privacy question of how to protect consumers’ neural data.
STAT in DC: Policy in Health Care
Join STAT’s leading DC bureau as they take the stage with policymakers, patient advocates, and industry experts to discuss the biggest issues in health policy…
U.S. to set limits on silica exposure first recommended half a century ago
For miners and other stone cutters, silica is a serious health hazard. New rules announced on Tuesday set strict limits on how much of the…
Eli Lilly’s Zepbound eases obstructive sleep apnea in trials
Eli Lilly reported Wednesday that the GLP-1 drug cut breathing interruptions in obese or overweight patients experiencing the condition.
How UnitedHealth’s acquisition of a popular Medicare Advantage algorithm sparked internal dissent over denied care
“It was very much about following the algorithms and basically not using your clinical judgment,” one former NaviHealth medical reviewer said. “That was very different…
High physician empathy could offer patients with lower back pain lasting benefits, study shows
A new study shows that high physician empathy could offer patients with lower back pain lasting benefits.
Amylyx’s Relvyvrio data was, as promised, disappointing
Amylyx’s data on its ALS drug, Relvyvrio, was, as promised, disappointing.